Hemangiomas In The Brain: Symptoms And Treatment Strategies


Definition and importance

Hemangiomas are benign (non-cancerous) tumours that develop within the blood vessels. When hemangiomas occur in the brain, they are known as cerebral hemangiomas, brain hemangiomas, or cavernous hemangiomas. These abnormal growths can affect brain function and cause various symptoms. Understanding the symptoms and treatment strategies for hemangiomas in the brain is crucial for proper management and care of affected individuals.

Explanation and prevalence

Hemangiomas are characterised by an abnormally rapid increase of blood vessels. They typically appear as red or purple nodules or patches on the skin or internal organs. Hemangiomas generally affect the brain and spinal cord; however, they can occur in other parts of the body, such as the liver, skin, and eyes. The prevalence of cerebral hemangiomas is relatively rare compared to other types of hemangiomas. However, their occurrence can have significant consequences due to the delicate nature of the brain and its vital functions.

Classification and types 

Hemangiomas in the brain can be classified into different types based on location, size, and blood vessel involvement. Some common types include:

  • Capillary hemangiomas: These are the most common type of cerebral hemangiomas. They involve the capillaries, which are the smallest blood vessels in the body. Capillary hemangiomas are typically small in size and may not cause significant symptoms unless they grow larger or affect critical areas of the brain.
  • Cavernous hemangiomas: Cavernous hemangiomas involve larger blood vessels called cavernous sinusoids. These abnormal clusters of blood vessels can grow and compress surrounding brain tissue, potentially leading to symptoms such as seizures, headaches, or neurological deficits.

Other types are venous malformations and arteriovenous malformations. While most cerebral hemangiomas are considered non-cancerous, they can still cause significant medical issues and require appropriate management.

In the next sections, we will discuss the symptoms commonly associated with hemangiomas in the brain and the available treatment strategies for addressing these tumours.


Common symptoms

  • Headaches: Persistent or recurrent headaches can occur due to the presence of a brain hemangioma.
  • Seizures: Hemangiomas in certain areas of the brain can trigger seizures, which are sudden abnormal electrical activities in the brain.
  • Visual disturbances: Depending on the location of the hemangioma, individuals may experience vision problems, such as blurred vision, double vision, or visual field defects.

Neurological manifestations

  • Weakness or numbness: Brain hemangiomas can cause weakness or numbness in specific body parts if they affect the regions of the brain responsible for motor control and sensation.
  • Difficulty speaking or understanding: Hemangiomas in certain language areas can lead to speech difficulties or comprehension problems.
  • Balance and coordination issues: Hemangiomas affecting the cerebellum or brainstem can disrupt the coordination of movements and balance, leading to unsteadiness or clumsiness.
  • Memory problems: In some cases, brain hemangiomas can impact memory function, leading to difficulties with short-term or long-term memory.

Impact on cognitive function

  • Learning difficulties: Hemangiomas in certain areas of the brain can affect cognitive processes, leading to difficulties in learning, attention, and concentration.
  • Behavioural changes: Some individuals may experience changes in behaviour, mood swings, or emotional instability due to the presence of a brain hemangioma.
  • Intellectual impairment: In rare cases, large or multiple hemangiomas in critical brain areas can result in intellectual disabilities.

Complications and risks

  • Bleeding: Although rare, brain hemangiomas can rupture and cause bleeding (haemorrhage) within the brain, leading to a medical emergency.
  • Increased intracranial pressure: As a hemangioma grows, it can exert pressure on surrounding brain tissue, potentially leading to increased intracranial pressure. This can cause symptoms such as severe headaches, nausea, vomiting, and changes in consciousness.
  • Neurological deficits: Depending on the location and size of the hemangioma, it can lead to long-term neurological deficits, such as paralysis, sensory loss, or language difficulties.


To diagnose brain hemangiomas, a healthcare professional will typically consider several factors and employ various diagnostic methods. These may include:

Medical history and examination

The healthcare provider may start by taking a detailed medical history to understand the patient's symptoms, their duration, and any associated factors. A thorough physical examination will be conducted to assess neurological function and look for any visible signs or symptoms that may suggest the presence of a brain hemangioma.

Imaging techniques

Imaging plays a crucial role in diagnosing brain hemangiomas. Magnetic resonance imaging (MRI) is the most commonly used imaging modality. It provides detailed images of the brain, allowing the healthcare professional to visualise and locate the hemangioma accurately.

Other imaging techniques such as computed tomography (CT) scans or angiography may be used in specific cases to provide additional information about the size, location, and blood supply to the hemangioma.

Biopsy and genetic testing

In some cases, a biopsy may be required to confirm the diagnosis. However, brain hemangiomas are generally diagnosed based on characteristic imaging findings, and a biopsy is not always necessary.

Genetic testing may be recommended in certain situations, especially when there is a suspicion of an inherited form of brain hemangioma, such as in patients with multiple hemangiomas or a family history of the condition.

Differential diagnosis

The diagnosis of brain hemangiomas involves considering other conditions with similar symptoms. The healthcare professional will perform a differential diagnosis to rule out other possible causes, which may include:

Treatment strategies4 

The treatment of brain hemangiomas depends on several factors, including the size, location, symptoms, and potential risks associated with the tumour. Here are some common treatment strategies employed:

Observation and monitoring

Small, asymptomatic hemangiomas that are not causing significant problems may be closely monitored over time. Regular imaging scans, such as MRI, can help track any changes in size or appearance. Regular follow-up appointments with a healthcare professional will allow for ongoing assessment of symptoms and the need for intervention.

Medication options

Medications may be prescribed to manage specific symptoms associated with brain hemangiomas. For example, antiepileptic drugs (AEDs) can help control seizures, while analgesics or migraine medications may be used to alleviate headaches.

Surgical interventions 5

Surgical removal of the hemangioma may be considered in certain cases. The decision for surgery depends on factors such as the size, location, and potential risks associated with the tumour. The surgical approach can vary and may involve techniques such as a craniotomy or minimally invasive procedures, depending on the individual case.

Radiation therapy

In some situations, radiation therapy may be recommended for brain hemangiomas that are not amenable to surgical removal. Radiation therapy can help shrink the tumour or reduce its blood supply, alleviating symptoms and preventing further growth.

Emerging approaches

Research into new treatment approaches for brain hemangiomas is ongoing. This includes the exploration of novel therapeutic agents, targeted therapies, and minimally invasive procedures.

Clinical trials may be available for individuals who are interested in participating and accessing potentially innovative treatment options.

Management and supportive care 6,7 

In addition to specific treatments, the management of brain hemangiomas involves providing supportive care to address associated symptoms and improve overall well-being. Here are some aspects of management and supportive care:

Pain management

If an individual experiences headaches or other types of pain related to the brain hemangioma, appropriate pain management strategies can be implemented. This may involve the use of medications prescribed by a healthcare professional to alleviate pain and improve comfort.

Seizure control

For individuals who experience seizures due to brain hemangiomas, antiepileptic drugs (AEDs) can be prescribed to help control and manage seizure activity. It is important to follow the prescribed medication regimen and regularly communicate with the healthcare provider regarding any changes in seizure frequency or severity.

Rehabilitation therapies

Depending on the specific symptoms and functional limitations caused by the hemangioma, various rehabilitation therapies can be beneficial. These may include physiotherapy to improve motor function and coordination, occupational therapy to enhance daily living skills, and speech and language therapy to address communication difficulties.

Psychological support

Dealing with a brain hemangioma diagnosis and its potential impact can be emotionally challenging. Therefore, psychological support is essential. This may involve counselling or therapy sessions with a psychologist or psychiatrist to address any psychological or emotional concerns related to the condition.

Multidisciplinary care 

Collaboration between healthcare professionals from different disciplines is crucial for comprehensive management. A multidisciplinary team, which may include neurologists, neurosurgeons, rehabilitation specialists, pain management experts, and psychologists, can provide a holistic approach to care and support.

Supportive care aims to improve the individual's quality of life, minimise symptoms, and enhance overall well-being. It is important for individuals with brain hemangiomas to maintain open communication with their healthcare team and promptly report any changes in symptoms or concerns. Regular follow-up appointments with healthcare professionals are necessary to assess the effectiveness of treatments, monitor any potential complications, and make adjustments to the management plan as needed.

Additionally, support groups or patient advocacy organisations can provide valuable resources and support for individuals and their families, offering opportunities to connect with others who may be going through similar experiences. Each individual's situation is unique and management strategies are tailored to their specific needs and circumstances.

Prognosis and outlook

The prognosis and outlook for individuals with brain hemangiomas can vary depending on several factors. Understanding the natural history of the condition, factors influencing prognosis, and the importance of follow-up care is essential.

Natural history

Brain hemangiomas can exhibit different growth patterns and behaviours. Some hemangiomas may remain stable in size and not cause significant symptoms, while others may grow or exhibit intermittent growth spurts. The natural history of brain hemangiomas can be influenced by factors such as their location, size, blood supply, and individual characteristics.

Factors affecting prognosis

  • Location and size: Hemangiomas located in critical areas of the brain or those that are large in size may pose a higher risk of complications and potentially impact prognosis.
  • Symptoms: The severity and type of symptoms experienced can also influence prognosis. Individuals with severe symptoms, such as recurrent seizures or neurological deficits, may require more intensive management and care.
  • Response to treatment: The response to treatments, such as surgical interventions or radiation therapy, can affect prognosis. Successful treatment outcomes may improve the long-term outlook.

Follow up care

Regular follow-up care is crucial for individuals with brain hemangiomas. This allows healthcare professionals to monitor any changes in the condition, assess treatment effectiveness, and manage potential complications. Follow-up care may involve periodic imaging scans, such as MRI, to evaluate the size and characteristics of the hemangioma. It also provides an opportunity to address any new or persistent symptoms and make necessary adjustments to the management plan.

The outlook for individuals with brain hemangiomas can vary widely, from minimal impact on daily life to more significant symptoms or complications. Prognosis and long-term outlook can be improved with early diagnosis, appropriate treatment, and ongoing monitoring. Regular communication with healthcare professionals and adherence to recommended follow-up care are vital for managing the condition effectively.

Prevention and risk reduction

While the development of brain hemangiomas is not entirely preventable, certain measures can help reduce the risk or mitigate potential complications. Here are some strategies that may be considered:

Lifestyle modifications

There are no specific lifestyle modifications known to directly prevent the development of brain hemangiomas. However, adopting a healthy lifestyle can contribute to overall well-being and potentially reduce the risk of other health conditions. Maintaining a balanced diet, engaging in regular exercise, managing stress levels, and avoiding tobacco and excessive alcohol consumption can promote general health and reduce the risk of certain health conditions that may indirectly impact the development or management of brain hemangiomas.

Genetic counselling

In some cases, brain hemangiomas can be associated with genetic factors. If there is a family history of brain hemangiomas or if multiple individuals in a family are affected, genetic counselling may be recommended. Genetic counselling involves an assessment of family history, genetic testing if appropriate, and providing information and support regarding the inheritance patterns and potential risks associated with the condition. This can help individuals make informed decisions regarding family planning and future health management.

Promising prevention measures

Currently, there are no specific prevention measures proven to completely prevent the development of brain hemangiomas. However, ongoing research is being conducted to explore potential preventive strategies. Promising areas of research include understanding the underlying genetic factors, exploring molecular pathways involved in hemangioma formation, and investigating novel therapeutic targets. These advancements may provide insights into potential preventive measures in the future.


Brain hemangiomas are benign tumours that develop in the blood vessels of the brain. Understanding their symptoms, treatment strategies, and management is crucial. Symptoms include headaches, seizures, visual disturbances, and neurological deficits. Diagnosis involves medical history, examination, and imaging techniques. Treatment options include observation, medication, surgery, radiation therapy, and supportive care. Prognosis varies based on factors such as location, size, and response to treatment. Prevention is not currently possible, but lifestyle modifications and genetic counselling may be considered. Overall, a multidisciplinary approach and adherence to treatment help manage brain hemangiomas effectively.


  1. Bokhari MR, Al-Dhahir MA. Brain cavernous angiomas. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Jul 9]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK430871/ 
  2. Li H, Zhang B, Wang W, Wei MH, Liu BY, Wu Z. Clinical features, intradural trans cavernous surgical management, and outcomes of giant cavernous sinus hemangiomas: a single-institution experience. World Neurosurgery [Internet]. 2019 May 1 [cited 2023 Jul 9];125:e754–63. Available from: https://www.sciencedirect.com/science/article/pii/S1878875019302657 
  3. Morrison L, Akers A. Cerebral cavernous malformation, familial. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, Gripp KW, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993 [cited 2023 Jul 9]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1293/ 
  4. Mouchtouris N, Chalouhi N, Chitale A, Starke RM, Tjoumakaris SI, Rosenwasser RH, et al. Management of cerebral cavernous malformations: from diagnosis to treatment. ScientificWorldJournal [Internet]. 2015 [cited 2023 Jul 9];2015:808314. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300037/ 
  5. Garrett M, Spetzler RF. Surgical treatment of brainstem cavernous malformations. Surgical Neurology [Internet]. 2009 Dec [cited 2023 Jul 9];72:S3–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0090301909005072 
  6. Eren Gozel H, Kök K, Ozlen F, Isler C, Pence S. A novel insight into differential expression profiles of sporadic cerebral cavernous malformation patients with different symptoms. Sci Rep [Internet]. 2021 Sep 29 [cited 2023 Jul 9];11(1):19351. Available from: https://www.nature.com/articles/s41598-021-98647-9 
  7. Dalyai RT, Ghobrial G, Awad I, Tjoumakaris S, Gonzalez LF, Dumont AS, et al. Management of incidental cavernous malformations: a review. FOC [Internet]. 2011 Dec [cited 2023 Jul 9];31(6):E5. Available from: https://thejns.org/view/journals/neurosurg-focus/31/6/2011.9.focus11211.xml 
This content is purely informational and isn’t medical guidance. It shouldn’t replace professional medical counsel. Always consult your physician regarding treatment risks and benefits. See our editorial standards for more details.

Get our health newsletter

Get daily health and wellness advice from our medical team.
Your privacy is important to us. Any information you provide to this website may be placed by us on our servers. If you do not agree do not provide the information.

Leona Issac

Bachelor of Dental Surgery, Rajiv Gandhi University of Health Sciences

Master of Public Health, University of Wolverhampton

Dr Leona Issac is a dynamic professional with a diverse background in dentistry and public health. With extensive experience as a dentist, she offers valuable insights into oral health, complemented by her Master’s degree in Public Health, which provides her with a comprehensive understanding of healthcare systems and their integration with dentistry. Her dedication to public health has led her to actively engage in health promotion, disease prevention and healthcare policy advocacy. Dr Leona continues to make a significant impact on the health and wellbeing of communities through her exceptional work and dedication to her field.

my.klarity.health presents all health information in line with our terms and conditions. It is essential to understand that the medical information available on our platform is not intended to substitute the relationship between a patient and their physician or doctor, as well as any medical guidance they offer. Always consult with a healthcare professional before making any decisions based on the information found on our website.
Klarity is a citizen-centric health data management platform that enables citizens to securely access, control and share their own health data. Klarity Health Library aims to provide clear and evidence-based health and wellness related informative articles. 
Klarity / Managed Self Ltd
Alum House
5 Alum Chine Road
Westbourne Bournemouth BH4 8DT
VAT Number: 362 5758 74
Company Number: 10696687

Phone Number:

 +44 20 3239 9818